Ebola virus DNA vaccine - Fresh Tracks Therapeutics/NIH
Alternative Names: Ebola DNA plasmid vaccine - Fresh Tracks Therapeutics/NIH; Multiple Strain Ebola DNA Plasmid Vaccine - NIAID; VRC-EBODNA012-00-VPLatest Information Update: 14 Sep 2022
At a glance
- Originator National Institutes of Health (USA); Vaccine Research Center
- Developer National Institutes of Health (USA)
- Class DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 16 Jul 2016 No recent reports of development identified for phase-I development in Ebola-virus-infections(Prevention) in USA (Parenteral, Injection)